Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The global pharmaceutical contract manufacturing/contract research market is anticipated to reach USD 238.3 billion by 2025, according to a new report by Grand View Research.
read more
Clinigen Group has signed an exclusive agreement with Lukare Medical to manage the supply and distribution of Elliotts B Solution.
read more
ICON plc announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and ...
read more
Wednesday, October 12, 2022
Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, has completed another expansion phase at its viral vector process development and cGMP vector ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Protea Biosciences announced it has integrated its therapeutic antibody analytical methods with new software developed by its partner, Protein Metrics.
read more
Saturday, September 25, 2021
The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD announced that ICON, a Dublin-based global provider of drug development and commercialisation services to pharmaceutical, biotechnology and medical device industries, has...
read more
Octapharma USA is extending funding for an IIS focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
read more
Wednesday, March 25, 2020
Signals Analytics has unveiled its COVID-19 Playbook, providing access to critical market intelligence and trends surrounding potential treatments for the novel coronavirus.
read more
Monday, November 08, 2021
Meiji Seika Pharma Co., Ltd. has been decided to construct a new manufacturing facility at Adcock Ingram Ltd. in Bengaluru, India.
read more
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria.
read more
Aragen, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it has operationalized the first phase of its biologics manufacturing facility in Bangalore, India through its 100% ...
read more
Tuesday, November 27, 2012
Clinical Research Advantage (CRA), the country’s largest community-based network of clinical trial sites, has entered into a strategic agreement with Quintiles to facilitate a higher level of clinical trial participation with an emphasis on safety, ...
read more
Wednesday, September 23, 2015
IDT Biologika has announced the dedication of its first U.S. vaccine manufacturing facility in Rockville, Maryland.
read more
Wednesday, December 26, 2018
Novacap announced that it will combine its Contract Development and Manufacturing Organization subsidiaries – PCI Synthesis, PCAS, Uetikon and Proteus – into a new entity to be known as SEQENS.
read more